Related references
Note: Only part of the references are listed.Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia
Cornelis Blauwendraat et al.
BRAIN (2020)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni et al.
LANCET NEUROLOGY (2020)
Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni et al.
MOVEMENT DISORDERS (2020)
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: a Kin Cohort Study
Roberta Balestrino et al.
MOVEMENT DISORDERS (2020)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study
Micol Avenali et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics
S. Pablo Sardi et al.
PARKINSONISM & RELATED DISORDERS (2019)
GBA-Associated Parkinson's Disease and Other Synucleinopathies
Ziv Gan-Or et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers
Noa Bregman et al.
BRAIN STRUCTURE & FUNCTION (2017)
Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers
Eileen E. Moran et al.
NEUROBIOLOGY OF AGING (2017)
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Elma Aflaki et al.
NEURON (2017)
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2016)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Neuropsychiatric characteristics of GBA-associated Parkinson disease
Matthew Swan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort
David Crosiers et al.
NEUROSCIENCE LETTERS (2016)
Differential effects of severe vs mild GBA mutations on Parkinson disease
Ziv Gan-Or et al.
NEUROLOGY (2015)
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort
Michelle Beavan et al.
JAMA NEUROLOGY (2015)
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls et al.
JAMA NEUROLOGY (2013)
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
Nuria Seto-Salvia et al.
MOVEMENT DISORDERS (2012)
Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2012)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
Functional Brain Imaging in Glucocerebrosidase Mutation Carriers With and Without Parkinsonism
Satoshi Kono et al.
MOVEMENT DISORDERS (2010)
Gaucher Disease Ascertained Through a Parkinson's Center: Imaging and Clinical Characterization
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Association of Glucocerebrosidase Mutations With Dementia With Lewy Bodies
Lorraine N. Clark et al.
ARCHIVES OF NEUROLOGY (2009)
Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations
Z. Gan-Or et al.
BRAIN (2009)
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
W. C. Nichols et al.
NEUROLOGY (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)